Immunotherapy
New Lung Cancer Treatment Approved
Posted on: November 13, 2015
Today, the U.S. Food and Drug Administration (FDA) granted accelerated approval for Tagrisso, an oral medication to treat patients with advanced non-small cell lung cancer (NSCLC). The FDA also approved the first companion diagnostic test (cobas EGFR Mutation Test v2) to detect the type of EGFR resistance mutation that Tagrisso (osimertinib) is known to target. Tagrisso… read more
Immunotherapy for Lung Cancer Patients
Posted on: November 2, 2015
For patients with advanced or metastatic lung cancer, the treatment options have traditionally been chemotherapy. First line treatment usually included a platinum containing chemotherapy. If cancer progressed after that, then the effectiveness of additional chemotherapy was limited. Now with immunotherapy, we have new and improved treatment options. The goal of immunotherapy is to stimulate the… read more
Shine a Light
Posted on: October 16, 2015
Join us to Shine a Light on Thursday, November 19 6:30-8:30 PM Walnut Creek Library – Oak Room 1644 N. Broadway, Walnut Creek, CA 94596 You are invited to an educational event focusing on the unique issues of lung cancer patients. Join an engaging panel of medical experts as they cover the most… read more
Immunotherapy Giving Hope for Cancer Patients
Posted on: July 1, 2015
There have been exciting advances in the area of immunotherapy for the treatment of cancer in 2015. Our immune system has the ability to differentiate self versus non-self. It also plays an important role in controlling cancer. This year’s American Society of Clinical Oncology meeting highlighted some new immunotherapy treatments for a number of cancers… read more
You folks turned a serious, potentially dangerous medical situation into an easy experience. It was a pleasure to work with top-rate professionals.
Hematology Patient
